TransMedics Group (TMDX) Competitors

Stevanato Group (NYSE:STVN) and TransMedics Group (NASDAQ:TMDX) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, community ranking, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

Which has better valuation & earnings, STVN or TMDX?

Stevanato Group has higher revenue and earnings than TransMedics Group. Stevanato Group is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	$1.10B	5.76	$157.62M	$0.48	43.75
TransMedics Group	$441.54M	5.36	-$25.03M	$1.01	69.62

Does the media prefer STVN or TMDX?

In the previous week, TransMedics Group had 46 more articles in the media than Stevanato Group. MarketBeat recorded 55 mentions for TransMedics Group and 9 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.27 beat TransMedics Group's score of 0.18 indicating that Stevanato Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TransMedics Group	9 Very Positive mention(s)	4 Positive mention(s)	34 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do institutionals and insiders believe in STVN or TMDX?

99.7% of TransMedics Group shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by insiders. Comparatively, 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Do analysts prefer STVN or TMDX?

TransMedics Group has a consensus target price of $122.70, suggesting a potential upside of 74.49%. Given TransMedics Group's stronger consensus rating and higher possible upside, analysts clearly believe TransMedics Group is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
TransMedics Group	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.82

Does the MarketBeat Community prefer STVN or TMDX?

TransMedics Group received 82 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 62.50% of users gave Stevanato Group an outperform vote while only 58.95% of users gave TransMedics Group an outperform vote.

Company	Underperform	Outperform
Stevanato Group	Outperform Votes 30 62.50%	Underperform Votes 18 37.50%
TransMedics Group	Outperform Votes 112 58.95%	Underperform Votes 78 41.05%

Is STVN or TMDX more profitable?

Stevanato Group has a net margin of 10.47% compared to TransMedics Group's net margin of 8.14%. TransMedics Group's return on equity of 18.74% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	10.47%	9.86%	5.79%
TransMedics Group	8.14%	18.74%	4.39%

Which has more risk & volatility, STVN or TMDX?

Stevanato Group has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500.

Summary

TransMedics Group beats Stevanato Group on 12 of the 19 factors compared between the two stocks.